Skip to main content

Table 9 Serious adverse events (number (%) unless otherwise stated)

From: Statistical analysis plan for a cluster randomised trial in Madhya Pradesh, India: community health promotion and medical provision and impact on neonates (CHAMPION2)

 

CHAMPION2 intervention arm

STRIPES2 intervention arm

Risk ratio

Counting pregnancies

x

x

 

Maternal blood transfusion

x (x)

x (x)

x (95% CI: x, x)

 Identified during routine follow-up

x (x)

x (x)

 

 Additionally identified at verbal autopsy

x (x)

x (x)

 

Mother admitted to hospital

x (x)

x (x)

x (95% CI: x, x)

 Identified during routine follow-up

x (x)

x (x)

 

 Identified at verbal autopsy

x (x)

x (x)

 

Days in hospital in those admitted

   

 1

x (x)

x (x)

 

 2

x (x)

x (x)

 

 3

x (x)

x (x)

 

 4

x (x)

x (x)

 

 5

x (x)

x (x)

 

 6

x (x)

x (x)

 

 7

x (x)

x (x)

 

 8

x (x)

x (x)

 

 9

x (x)

x (x)

 

 10

x (x)

x (x)

 

 11+

x (x)

x (x)

 

Babies from counting pregnancies

x

x

 

Baby admitted to hospital

x (x)

x (x)

x (95% CI: x, x)

 Identified during routine follow-up

x (x)

x (x)

 

 Identified at verbal autopsy

x (x)

x (x)

 

Days in hospital in those admitted

   

 1

x (x)

x (x)

 

 2

x (x)

x (x)

 

 3

x (x)

x (x)

 

 4

x (x)

x (x)

 

 5

x (x)

x (x)

 

 6

x (x)

x (x)

 

 7

x (x)

x (x)

 

 8

x (x)

x (x)

 

 9

x (x)

x (x)

 

 10

x (x)

x (x)

 

 11+

x (x)

x (x)

Â